Last week EVERSANA™ and our joint venture partner, Intouch Group®, announced the that they signed an agreement to incorporate Intouch’s industry-leading creative and media services, enterprise solutions and data analytics into EVERSANA’s fully integrated commercialization services platform.
Together, the combined companies - with more than 40 global locations; 5,500 employees worldwide; and millions of dollars invested in digital transformation, data and analytics - are poised to deliver full-scale commercialization to pharmaceutical companies globally.
The Intouch agency network, including its nine affiliates (Intouch Solutions, Intouch Proto, Intouch Seven, Intouch International, Intouch Media, Intouch B2D, Intouch Analytics, Intouch Market Access, and Intouch Oxygen), are further strengthened by and will propel EVERSANA’s commercial services platform spanning the complete product life cycle. The agency will immediately work closely with EVERSANA’s agency, EVERSANA ENGAGE.
Under terms of the agreement, both companies and their clients will immediately benefit from access to the full array of digitally driven, patient-centric services designed to solve any global pricing, access, reimbursement, promotion, adherence, or product delivery challenge.
At Healthware we will continue our successful joint venture journey with Intouch and we're looking forward to this incredible opportunity to continue to disrupt and evolve the industry in positive ways within and even larger family.
Read more about what’s to come for Intouch and EVERSANA here.